TY - JOUR
T1 - Identifying and responding to policy-related barriers, facilitators, and misunderstandings in the HEALing communities study
T2 - A community-driven approach
AU - Silwal, Anita
AU - Bohler, Robert
AU - Hunt, Timothy
AU - Olvera, Ramona G.
AU - Lofwall, Michelle R.
AU - Cook, Christopher D.
AU - Marks, Katherine R.
AU - Bridden, Carly
AU - Freeman, Patricia R.
AU - Nouvong, Monica
AU - Fanucchi, Laura C.
AU - El-Bassel, Nabila
AU - Frazier, Lisa A.
AU - Walsh, Sharon L.
AU - Talbert, Jeffery C.
N1 - Copyright © 2025 Elsevier B.V. All rights reserved.
PY - 2025/5/22
Y1 - 2025/5/22
N2 - Introduction: The HEALing (Helping to End Addiction Long-Term®) Communities Study (HCS) aimed to reduce opioid-involved overdose deaths across four states (Kentucky, Massachusetts, New York, and Ohio) via community-engaged implementation of three evidence-based practices (EBPs): (1) opioid overdose education and naloxone distribution, (2) medication for opioid use disorder expansion/linkage/retention, and (3) safer opioid prescribing and dispensing practices. A policy workgroup (PWG) was convened and developed a procedure to identify and address policies potentially impacting EBP implementation. Methods: A five-step method was developed to identify, track, and respond to relevant policies at three of the research sites (Kentucky, Massachusetts, and New York) in collaboration with community partners and stakeholders. Policies possibly impacting EBPs were reported, reviewed, and documented, including any actions taken to address the policy issue. Policies were discussed with local, state, and federal level stakeholders in attempts to resolve barriers, clarify misunderstandings, and disseminate facilitators. Results: A total of 87 (Kentucky = 37; Massachusetts = 19; New York = 31) policies were identified and addressed; 42 were identified as barriers, 24 as facilitators, and 21 as misunderstandings. PWG efforts resolved over 73 % (n = 31) of policy barriers, clarified 90 % (n = 19) of policy misunderstandings, and disseminated 100 % (n = 24) of policy facilitators. Conclusions: A community-driven approach in policy surveillance identified, addressed, and disseminated several different types of policy issues that could impact implementation of EBPs for opioid-involved overdose prevention. Many policy barriers persisted during the HCS study, which may have adversely affected study outcomes.
AB - Introduction: The HEALing (Helping to End Addiction Long-Term®) Communities Study (HCS) aimed to reduce opioid-involved overdose deaths across four states (Kentucky, Massachusetts, New York, and Ohio) via community-engaged implementation of three evidence-based practices (EBPs): (1) opioid overdose education and naloxone distribution, (2) medication for opioid use disorder expansion/linkage/retention, and (3) safer opioid prescribing and dispensing practices. A policy workgroup (PWG) was convened and developed a procedure to identify and address policies potentially impacting EBP implementation. Methods: A five-step method was developed to identify, track, and respond to relevant policies at three of the research sites (Kentucky, Massachusetts, and New York) in collaboration with community partners and stakeholders. Policies possibly impacting EBPs were reported, reviewed, and documented, including any actions taken to address the policy issue. Policies were discussed with local, state, and federal level stakeholders in attempts to resolve barriers, clarify misunderstandings, and disseminate facilitators. Results: A total of 87 (Kentucky = 37; Massachusetts = 19; New York = 31) policies were identified and addressed; 42 were identified as barriers, 24 as facilitators, and 21 as misunderstandings. PWG efforts resolved over 73 % (n = 31) of policy barriers, clarified 90 % (n = 19) of policy misunderstandings, and disseminated 100 % (n = 24) of policy facilitators. Conclusions: A community-driven approach in policy surveillance identified, addressed, and disseminated several different types of policy issues that could impact implementation of EBPs for opioid-involved overdose prevention. Many policy barriers persisted during the HCS study, which may have adversely affected study outcomes.
KW - Analgesics, Opioid/administration & dosage
KW - Evidence-Based Practice
KW - Health Policy
KW - Humans
KW - Massachusetts
KW - Naloxone/administration & dosage
KW - Narcotic Antagonists/administration & dosage
KW - New York
KW - Opiate Overdose/prevention & control
KW - Opioid-Related Disorders/drug therapy
KW - United States
UR - http://www.scopus.com/inward/record.url?scp=105005646094&partnerID=8YFLogxK
U2 - 10.1016/j.drugpo.2025.104851
DO - 10.1016/j.drugpo.2025.104851
M3 - Article
C2 - 40409135
AN - SCOPUS:105005646094
SN - 0955-3959
VL - 142
JO - International Journal of Drug Policy
JF - International Journal of Drug Policy
M1 - 104851
ER -